微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 39.33% | -22.34% | -0.95% | 42/55 | 65.82% | 我武生物 | 95.37% | 行业排名> |
| 2025-06-30 | 39.71% | -22.25% | 3.49% | 45/55 | 67.7% | 我武生物 | 95.1% | 行业排名> |
| 2025-03-31 | 38.37% | -22.55% | -21.83% | 45/55 | 69.02% | 金迪克 | 95.24% | 行业排名> |
| 2024-12-31 | 49.09% | 12.82% | -3.09% | 43/55 | 68.55% | 我武生物 | 95.16% | 行业排名> |
| 2024-09-30 | 50.65% | 18.81% | -0.83% | 41/55 | 69.18% | 我武生物 | 95.26% | 行业排名> |
| 2024-06-30 | 51.08% | 29.14% | 3.09% | 40/55 | 68.3% | 西藏药业 | 95.7% | 行业排名> |
| 2024-03-31 | 49.55% | 41.24% | 13.87% | 41/55 | 69.14% | 康华生物 | 96.08% | 行业排名> |
| 2023-12-31 | 43.51% | 35.92% | 2.06% | 41/55 | 68.02% | 我武生物 | 95.26% | 行业排名> |
| 2023-09-30 | 42.63% | 30.52% | 7.8% | 41/55 | 68.07% | 我武生物 | 95.4% | 行业排名> |
| 2023-06-30 | 39.55% | 18.52% | 12.74% | 43/55 | 63.32% | 华兰疫苗 | 101.02% | 行业排名> |
| 2023-03-31 | 35.08% | 13.32% | 9.58% | 44/55 | 69.48% | 华兰疫苗 | 100.22% | 行业排名> |
| 2022-12-31 | 32.01% | -21.86% | -2% | 46/55 | 68.17% | 我武生物 | 95.39% | 行业排名> |
| 2022-09-30 | 32.67% | -23.92% | -2.11% | 44/55 | 71.28% | 我武生物 | 95.63% | 行业排名> |
| 2022-06-30 | 33.37% | -23.01% | 7.8% | 46/55 | 69.18% | 我武生物 | 95.75% | 行业排名> |
| 2022-03-31 | 30.96% | -27.35% | -24.44% | 40/55 | 71.63% | 华兰疫苗 | 98.39% | 行业排名> |
| 2021-12-31 | 40.97% | -15.86% | -4.58% | 45/55 | 72.1% | 百奥泰 | 95.74% | 行业排名> |
| 2021-09-30 | 42.94% | -12.02% | -0.94% | 41/55 | 73.87% | 我武生物 | 95.89% | 行业排名> |
| 2021-06-30 | 43.34% | -0.72% | 1.72% | 42/55 | 73.72% | 百奥泰 | 96.33% | 行业排名> |
| 2021-03-31 | 42.61% | 3.81% | -12.49% | 33/55 | 73.03% | 义翘神州 | 96.83% | 行业排名> |
| 2020-12-31 | 48.69% | 0.62% | -0.23% | 39/55 | 71.61% | 义翘神州 | 96.88% | 行业排名> |
| 2020-09-30 | 48.81% | -0.35% | 11.8% | 30/55 | 73.64% | 义翘神州 | 96.56% | 行业排名> |
| 2020-06-30 | 43.66% | -11.42% | 6.36% | 39/55 | 88.2% | 华兰疫苗 | 707.43% | 行业排名> |
| 2020-03-31 | 41.05% | -11.78% | -15.18% | 29/55 | 70.26% | 我武生物 | 95.6% | 行业排名> |
| 2019-12-31 | 48.39% | -3.62% | -1.2% | 36/55 | 72.44% | 我武生物 | 96.43% | 行业排名> |
| 2019-09-30 | 48.98% | -3.29% | -0.62% | 24/55 | 70.09% | 我武生物 | 96.51% | 行业排名> |
| 2019-06-30 | 49.29% | -1.5% | 5.93% | 22/55 | 69.35% | 我武生物 | 96.46% | 行业排名> |
| 2019-03-31 | 46.53% | -7.9% | -7.33% | 21/55 | 69.07% | 我武生物 | 96.44% | 行业排名> |
| 2018-12-31 | 50.21% | -5.24% | -0.86% | 32/55 | 71.54% | 康辰药业 | 95.1% | 行业排名> |
| 2018-09-30 | 50.64% | -6.39% | 1.22% | 20/55 | 67.51% | 康辰药业 | 94.98% | 行业排名> |
| 2018-06-30 | 50.04% | -6.6% | -0.95% | 21/55 | 67.2% | 康辰药业 | 94.9% | 行业排名> |
| 2018-03-31 | 50.52% | -4.25% | -4.66% | 17/55 | 65.03% | 我武生物 | 93.37% | 行业排名> |
| 2017-12-31 | 52.99% | -0.34% | -2.06% | 29/55 | -887.82% | 我武生物 | 96.35% | 行业排名> |
| 2017-09-30 | 54.1% | 0.74% | 1% | 17/55 | 65.93% | 我武生物 | 97% | 行业排名> |
| 2017-06-30 | 53.57% | 3.72% | 1.54% | 20/55 | 63.83% | 我武生物 | 96.96% | 行业排名> |
| 2017-03-31 | 52.76% | -11.66% | -0.77% | 17/55 | 65.37% | 我武生物 | 97.16% | 行业排名> |
| 2016-12-31 | 53.17% | 11.44% | -1% | 22/55 | 68.41% | 欧林生物 | 99.46% | 行业排名> |
| 2016-09-30 | 53.71% | -8.57% | 3.98% | 16/55 | 63.02% | 我武生物 | 95.96% | 行业排名> |
| 2016-06-30 | 51.65% | -28.12% | -13.52% | 18/55 | -3007.12% | 欧林生物 | 99.4% | 行业排名> |
| 2016-03-31 | 59.72% | -21.77% | 25.17% | 13/55 | 61.6% | 我武生物 | 95.8% | 行业排名> |
| 2015-12-31 | 47.71% | -39.28% | -18.77% | 23/55 | 65.23% | 欧林生物 | 99.33% | 行业排名> |
| 2015-09-30 | 58.74% | -25.58% | -18.26% | 13/55 | 60.32% | 我武生物 | 95.02% | 行业排名> |
| 2015-06-30 | 71.86% | -8.67% | -5.87% | 7/55 | 61.38% | 我武生物 | 94.71% | 行业排名> |
| 2015-03-31 | 76.34% | -5.7% | -2.84% | 4/55 | 57.69% | 我武生物 | 95.59% | 行业排名> |